Regro Scalp Usage And Safety
Dosage
Minoxidil Solution
Side Effects
Accidental ingestion may produce systemic effects related to the vasodilatory action of Minoxidil. Signs and symptoms of drug overdosage would most likely be cardiovascular effects associated with fluid retention, lowered blood pressure and tachycardia. Fluid retention can be managed with appropriate diuretic therapy. Tachycardia can be controlled by administration of a beta adrenergic blocking agent. Hypotension should be treated by intravenous administration of normal saline. Sympathomimetic drugs, such as norepinephrine and epinephrine should be avoided because of their excessive cardiac stimulating activity.
Drug Interactions
There are currently no known interactions associated with the use of Minoxidil Topical Solution.
Indication
Minoxin (Minoxidil Topical Solution USP) is indicated for treatment of androgenetic alopecia, expressed in males as baldness of the vertex of the scalp and in females as diffuse hair loss or thinning of frontoparietal area. At least, 4 (four) months of twice daily application of Minoxin (Minoxidil Topical Solution USP) are generally required before evidence of hair growth can be expected.
When not to Use
Minoxin (Minoxidil Topical Solution USP) is contra-indicated in those patients with a history of hypersensitivity to any component of the preparation.
Regro Scalp Warnings
Warning 1
Minoxin (Minoxidil Topical Solution USP) will cause burning and irritation to the eye. In the event of accidental contact with sensitive surface (eye, abraded skin, mucous membranes), the area should be bathed with copious amounts of cool tap water.
Warning 2
Minoxin (Minoxidil Topical Solution USP) should not be used in conjunction with other topical agents including corticosteroids, retinoids and petrolatum or agents that are known to enhance cutaneous drug absorption.
Warning 3
Safety and effectiveness of Minoxidil Topical Solution in patients under 18 years of age have not been established.
